To assess the effect of macrophage ATG16L1 on the progression of liver fibrosis, we generated myeloid-specific Atg16l1-deficient (Atg16l1ΔMφ) and Atg16l1-proficient (Atg16l1FL/FL) mice. Here, ATG16L1 is linked to Hepatic fibrosis.